|

Pegcrisantaspase Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Asparec, JZP 416, JZP-416, JZP416, Pegylated Erwinia asparaginase +2 more

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Down Syndrome1
  • Recurrent B Acute Lymphoblastic Leukemia1
  • Cancer1

Birmingham, Alabama1 trial

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Children's Hospital of Alabama

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.